Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Free Cash Flow: 2021-2024

Historic Free Cash Flow for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$10.3 million.

  • Biofrontera's Free Cash Flow fell 202.71% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year increase of 34.31%. This contributed to the annual value of -$10.3 million for FY2024, which is 58.60% up from last year.
  • As of FY2024, Biofrontera's Free Cash Flow stood at -$10.3 million, which was up 58.60% from -$24.9 million recorded in FY2023.
  • Biofrontera's 5-year Free Cash Flow high stood at -$10.3 million for FY2024, and its period low was -$26.7 million during FY2021.
  • Its 3-year average for Free Cash Flow is -$17.2 million, with a median of -$16.2 million in 2022.
  • As far as peak fluctuations go, Biofrontera's Free Cash Flow slumped by 53.37% in 2023, and later skyrocketed by 58.60% in 2024.
  • Yearly analysis of 4 years shows Biofrontera's Free Cash Flow stood at -$26.7 million in 2021, then soared by 39.24% to -$16.2 million in 2022, then tumbled by 53.37% to -$24.9 million in 2023, then spiked by 58.60% to -$10.3 million in 2024.